Pharmaceutical drug delivery refers to the process and technologies involved in delivering therapeutic substances to the desired site within the body, at the required concentration and for the time required to achieve effective treatment. The focus on drug delivery often centers around optimizing the formulation of drugs to enhance their efficacy, safety, and patient compliance. The formulation of drug delivery involves the development of a dosage form that ensures the proper release, absorption, and distribution of the drug within the body.
The pharmaceutical drug delivery market consists of sales, by entities (organizations, sole traders and partnerships) that are consumed in forms such as oral tablet, syrups and others. The drug delivery systems can take various forms, including oral tablets, capsules, injectables, transdermal patches, inhalers and other innovative delivery mechanisms. The market focuses on the different types of formulation used in pharmaceutical drug delivery.
The global pharmaceutical drug delivery market was valued at $1,175.1 billion in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 6.0%.
Increased Prevalence Of Chronic Diseases
Increased prevalence of chronic diseases such as asthma and chronic obstructive pulmonary disease (COPD) drove the market for pharmaceutical drug delivery during the historic period. With a growing global burden of conditions such as diabetes, cardiovascular diseases and autoimmune disorders, there is a heightened demand for effective and patient-friendly drug delivery solutions. The rise in chronic diseases necessitates long-term medication regimens, emphasizing the importance of delivery systems that enhance patient adherence, improve therapeutic outcomes and minimize side effects. According to the International Diabetes Federation, a Belgium-based umbrella organization of over 230 national diabetes associations' globally, almost 7 million new patients are diagnosed with diabetes every year. Further, in July 2022, according to Health Affairs, a monthly peer-reviewed healthcare journal, an estimated 37.3 million Americans had type 2 diabetes, an increase of more than 40% from a decade ago, which augmented the need for drugs for diabetic patients. Therefore, the increased patient pool globally drove the pharmaceutical drugs market during the historic period.
Advancements In Acne Treatment Formulations
Major pharmaceutical drug delivery companies are focusing on advancements in acne treatment formulations to expand their product portfolio and drive revenues. Advancements in formulations often coincide with innovations in active ingredients. New compounds or combinations of existing compounds may be introduced to the market, expanding the range of treatment options available to healthcare providers and patients. For example, in December 2023, Sun Pharma Canada Inc., a Canada-based pharma company, launched a PRABSORICA LD (isotretinoin capsules) in Canada. This marks a significant development, as ABSORICA LD represents a new formulation of isotretinoin, the first in over a decade.
The global pharmaceutical drug delivery market is fairly concentrated, with a large number of players operating in the market. The top ten competitors in the market made up to 27.01% of the total market in 2022.
Pharmaceutical Drug Delivery Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global pharmaceutical drug delivery market as it emerges from the COVID-19 shut down.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Where is the largest and fastest-growing market for pharmaceutical drug delivery? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The pharmaceutical drug delivery market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider pharmaceutical drug delivery market; and compares it with other markets.
The report covers the following chapters
- Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by route of administration, segmentation by application and by end-user.
- Key Trends- Highlights the major trends shaping the pharmaceutical drug delivery market. This section also highlights likely future developments in the market.
- Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the pharmaceutical drug delivery market.
- Global Market Size and Growth Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
- Regional And Country Analysis Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
- Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by route of administration, segmentation by application and by end-user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
- Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
- Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
- Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
- Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
- Conclusions And Recommendations- This section includes recommendations for pharmaceutical drug delivery providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
- Appendix This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Markets Covered:
- 1) By Route of Administration: Oral; Ocular; Pulmonary; Nasal; Injectable; Topical; Other Routes
- 2) By Application: Cancer; Infectious Diseases; Central Nervous System Disorders; Respiratory Diseases; Cardiovascular Diseases; Musculoskeletal Disorders; Metabolic Disorders; Other Applications
- 3) By End User: Hospitals; Home Care Settings; Ambulatory Surgery Centers/Clinics; Other End Users
- Companies Mentioned: Pfizer Inc.; AbbVie Inc; Johnson & Johnson; Merck & Co., Inc.; Sanofi
- Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; , Italy; Spain; Russia
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time-series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; pharmaceutical drug delivery indicators comparison.
- Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.